Head-to-head · WeighScore
Hims & Hers vs Elara Health and Wellness
The verdict
Elara Health and Wellness takes it — 82/100 to 80/100, but only just.
Elara Health and Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low-ish both-molecule pricing ($117/$196), nationwide — but unverified. Hims & Hers is close behind and may still be the better fit — see the factor split below.
Both are editorial reviews with no commercial relationship.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Hims & Hers | Elara Health and Wellness |
|---|---|---|
| WeighScore | 80/100 | 82/100 |
| Grade | B− | B− |
| Scorecard rank | #22 | #20 |
| Semaglutide | $199/mo | $117/mo |
| Tirzepatide | Not disclosed | $196/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| Relationship | Editorial | Editorial |
Graded #22 · B−
Strengths
- Nationwide
- Polished app
- Strong brand trust
Where it loses points
- Tirzepatide pricing inconsistently disclosed
- Industry-wide compounding scrutiny
Graded #20 · B−
Strengths
- $117 semaglutide
- All 50 states
- Both molecules
Where it loses points
- Not LegitScript-verified
- Tirzepatide $196
- Monitoring detail sparse
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 25 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.